Study: NCT04626635

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7075
Description: Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Administered concomitantly Q3W by IV infusion or SC injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-based doublet chemotherapy
Description: Administered IV Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum-based doublet chemotherapy
Description: Administered IV Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine-tipiracil
Description: Administered per protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine-tipiracil
Description: Administered per protocol